Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Lithuania, Taiwan need to defend rules-based order for survival: Ex-FM
01/15/2025 05:03 PM - Business
Taiwan shares under heavy losses on futures-led sell-off
01/15/2025 05:02 PM - Society
Lunar New Year garbage collection schedules in Taiwan's major cities
01/15/2025 04:48 PM - Politics
Taiwan to strengthen surveillance near undersea cables
01/15/2025 04:34 PM - Business
U.S. dollar closes higher on Taipei forex market
01/15/2025 04:26 PM